Finding the Optimal Location for Saturation Measurement During Flexible Bronchoscopy

Optimal Location of Saturation Measurement During Flexible Fiberoptic Bronchoscopy

Sponsors

Lead Sponsor: Rabin Medical Center

Source Rabin Medical Center
Brief Summary

An observational comparison of different locations of saturation measurements during Flexible Bronchoscopy

Detailed Description

The study group will include 100 patients undergoing flexible fiberoptic bronchoscopy (FFB).

The patients will receive sedation with Midazolam, Fentanyl and Propofol. All patients will receive supplemental oxygen via nasal cannula (2-4 L/min) before the beginning of the procedure.

In all cases, patients will be monitored using continuous electrocardiography, pulse oximetry (on patients finger), and transcutaneous carbon dioxide and saturation (on patients earlobe), and automated noninvasive blood pressure recordings every 5 minutes. All parameters will be recorded from accepting patient to bed of procedure until 10 minutes after removal of FFB from nasopharynx.

The saturation will be measured in 3 different locations (one pulse is added in other earlobe). additionally, A blood gas sample will be taken during discrepancy between different measurements.

Immediately after the end of procedure, the measurements from 3 different monitors will be printed, and the blood sample be taken to a gas sample machine by the investigator.

Desaturation value and time will be compared between the different locations. The blood arterial saturation will be compared to other measurements taken at the same time.

Overall Status Completed
Start Date January 1, 2017
Completion Date March 30, 2017
Primary Completion Date March 30, 2017
Study Type Observational
Primary Outcome
Measure Time Frame
Value changes between locations Through completion of bronchoscopy procedure an average of 30 minutes
Time changes between locations Through completion of bronchoscopy procedure an average of 30 minutes
Secondary Outcome
Measure Time Frame
gap between arterial gas sample and different monitors Through completion of bronchoscopy procedure an average of 30 minutes
Enrollment 116
Condition
Intervention

Intervention Type: Diagnostic Test

Intervention Name: blood gas sampling

Eligibility

Sampling Method: Non-Probability Sample

Criteria:

Inclusion Criteria:

- informed consent

Exclusion Criteria:

-

Gender: All

Minimum Age: 18 Years

Maximum Age: 100 Years

Overall Official
Last Name Role Affiliation
Mordechai R Kramer, MD Principal Investigator Rabin Medical Center, Belinson Hospital
Location
Facility: Pulmonary Institute Rabin Medical Center
Location Countries

Israel

Verification Date

March 2017

Responsible Party

Type: Principal Investigator

Investigator Affiliation: Rabin Medical Center

Investigator Full Name: Mordechai Kremer

Investigator Title: Head of Pulmonary Institute

Keywords
Has Expanded Access No
Condition Browse
Patient Data No
Study Design Info

Observational Model: Case-Only

Time Perspective: Prospective

Source: ClinicalTrials.gov